Navigation Links
Dermatologists identify North Texas leishmaniasis outbreak
Date:9/14/2007

DALLAS Sept. 14, 2007 A team of dermatologists and dermatopathologists at UT Southwestern Medical Center has identified nine North Texas cases of an infectious skin disease common in South America, Mexico and in the Middle East, where it is sometimes referred to as a Baghdad boil.

Numerous cases of the disease, called leishmaniasis, have been reported in troops returning from Iraq and Afghanistan. But for the first time, cases of this dangerous infection are appearing in North Texas in patients who have not traveled to endemic areas.

The infection causes nonhealing sores that can be the size of a half-dollar or larger and that look like boils. These sores usually last for 6 to 12 months and because they are often mistaken for a staph infection, patients may have been given multiple courses of standard antibiotics without success.

The disease is caused by a single-celled parasite called Leishmania, and special cultures must be done in order to confirm the diagnosis of leishmaniasis.

The identified cases were from Waxahachie, Hillsboro and Glenn Heights, all areas south of Dallas; Tom Bean, Anna, Savoy and Nevada, all north of Dallas; and North Richland Hills.

North Texas doctors must have a high index of suspicion and understand that this organism must now be considered endemic in this area, said Dr. Kent Aftergut, a clinical instructor of dermatology at UT Southwestern and in private practice at Methodist Charlton Medical Center.

Luckily, all of the leishmaniasis cases in North Texas that have been cultured have grown Leishmania mexicana, which is less dangerous than other forms of the parasite, he said. It makes skin sores, but the infection doesnt spread and become a full body disease like some of the others species of Leishmania. Usually, if patients have a normal immune system, the sores will resolve in six to 12 months and wont make the patients ill.

In North Texas, doctors suspe
'/>"/>

Contact: Russell Rian
russell.rian@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Dermatologists Provide Unique Evidence of Possible Cause of Rare Skin Condition
2. Chances of Survival for Melanoma is High When Detected by Dermatologists
3. Sunbathers Beware of Skin Cancer, Dermatologists Warn
4. Holy Grail Of Dermatologists On The Verge Of Discovery
5. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
6. Now you can identify Sperm and Egg donors
7. Identifying Predictors Of Anthrax
8. Identifying The Risks Of Developing Schizophrenia
9. Researchers identify the early makers of Neonatal Sepsis
10. Researchers Identify Gene Connected To Bipolar Disorder
11. Blood test may identify ovarian cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... 2013 People in Minnesota have a great ... is offering its 28 Day Fat Loss Formula. The ... comfort of their own home. The product sells for $135 ... can be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season ... houses now, but after using the 28 Day Fat Loss ...
(Date:5/19/2013)... May 19, 2013 The muscles in ... their functionality and one of the biggest and most ... nervous system. The peripheral system comprises of peripheral nerves ... cord. These nerves ensure that the limbs and hands, ... when these nerves get damaged due to trauma or ...
(Date:5/19/2013)... According to a new market research report ... 2018): By Applications (Healthcare (Endoscopy, Radiology, Ophthalmology), Surveillance, ... IS, Infrared, X-Ray) And Geography" published by MarketsandMarkets, ... billion in 2012 and is expected to reach ... of 3.84% from 2013 to 2018. In terms ...
(Date:5/19/2013)... May 19, 2013 The report “Feed ... Trends & Forecasts up to 2017” published by MarketsandMarkets, ... with analysis and forecasting of the global volume and ... the driving and restraining factors for the global market ... and challenges. The market is segmented and revenue is ...
(Date:5/19/2013)... Americans live closer to their dogs than ever ... Association (AVMA) U.S. Pet Ownership and Demographics Sourcebook, more ... a member of the family, up from the 53.5% ... earlier. , According to the American Pet Products Association, ... to pets has increased every year without interruption, including ...
Breaking Medicine News(10 mins):Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3
... WEDNESDAY, Oct. 26 (HealthDay News) -- A vaccine to prevent ... bisexual males, according to a study funded in part by ... papilloma virus (HPV), the most common sexually transmitted disease in ... and bisexual men and people infected with HIV. , ...
... the nipple is highly effective in animal models of early ... patients, according to a report by Johns Hopkins Kimmel Cancer ... 26. The results of the study are expected to lead ... early breast cancer. "Our results support the theory that ...
... human eye is as comfortable with white light generated ... popular light-emitting diodes (LEDs), according to tests conceived at ... through material to generate light, but the simpler LED ... light back and forth internally before releasing it. ...
... University Hospital surgeons found that a carefully-selected surgical care ... by nearly 50 percent. Smoking cessation at ... prior to skin closure, and using clippers over razors to ... helped reduced infection rates, according to the study published in ...
... what is so far the largest investigation of its kind, ... diseases and how they are affected by differences between two ... highly targeted, individualized therapies. Led by researchers from Weill ... edition of the journal Nature , the study provides ...
... Bisphenol A (BPA) -- a substance that may have ... thermal cash register receipts, scientists are reporting. The recycling ... BPA contamination of paper napkins, toilet paper, food packaging ... special implications for cashiers and other people who routinely ...
Cached Medicine News:Health News:HPV Vaccine Might Help Prevent Anal Cancers: Study 2Health News:Through-the-nipple breast cancer therapy shows promise in early tests 2Health News:Through-the-nipple breast cancer therapy shows promise in early tests 3Health News:High-quality white light produced by four-color laser source 2Health News:High-quality white light produced by four-color laser source 3Health News:Thomas Jefferson University Hospital cuts Whipple procedure wound infections in half with new measures 2Health News:Study identifies genetic basis of human metabolic individuality 2
(Date:5/17/2013)... PHILADELPHIA , May 17, 2013 ... disorders; health economics and outcomes research also   to ... SHP, NASDAQ: SHPG ), the global specialty ... in 7 poster presentations at the American Psychiatric Association ... , May 18-22. The data being presented represent ...
(Date:5/17/2013)... -- Fuse Science, Inc. (OTCQB: DROP), ( www.fusescience.com ) a ... patent-pending technologies poised to redefine how consumers receive energy, medicines, ... business update teleconference and webcast for shareholders and the investment ... PM ET. Fuse Science, Inc. CEO, ... will be joined by Rubin Hanan , ...
(Date:5/17/2013)... May 17, 2013 Oramed Pharmaceuticals ... oral drug delivery systems, announced today that the United ... Company,s Investigational New Drug application(IND) for ORMD-0801, its oral ... have the FDA clearance to proceed," stated ... trial is a major milestone for Oramed and we ...
Breaking Medicine Technology:Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3
... STAA ) today announced that it will release financial results for ... 2, 2009 after the market close. ... Tuesday, November 3, 2009 at 10:00 a.m. Eastern / 7:00 a.m. ... quarter results and current corporate developments. The timing of the release ...
... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today announced ... COR-I and COR-II Phase 3 trials of Contrave® (naltrexone SR/bupropion ... the treatment of obesity. These data expand on top-line ... discussion on Saturday where the Company presented data on Contrave ...
Cached Medicine Technology:STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call 2Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society 2Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society 3Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society 4Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society 5Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society 6
Irrigating Cystotome, Straight, 25 g. Overall length 15 mm. 5/box....
Irrigating Cystotome, formed, 23 g., 12 mm curved tip. Overall length 14 mm. 5/box....
Peribulbar Needle, 23 g. Atkinson style bevel. Overall length 31 mm. 5/box....
Lamellar Blade tip 6600 style, angled bevel up. Dimensions: 11.0 mm (L) x 2.4 mm (W). Cut: 3.7 mm....
Medicine Products: